Mākala manō

Anter

• Kūpono ʻole paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO ka cartilage shark (nā mea ʻeleʻele paʻakikī e hāʻawi i ke kākoʻo, e like me ka iwi) i hoʻohana ʻia no ka lāʻau mai nā manō i hopu ʻia i ka Moana Pākīpika. Hana ʻia kekahi mau ʻano o nā extracts mai ka cartilage manō e like me ka squalamine lactate, AE-941, a me U-995.

Hoʻohana kaulana ʻia ka cartilage manō no ka maʻi ʻaʻai. Hoʻohana pū ʻia ka cartilage shark no ka osteoarthritis, ka lāʻau plaque, ka nalowale o ka hihi e pili ana i ka makahiki, ka hōʻeha ʻana i ka ʻeha, ka hōʻino ʻia o ka retina o ka maka ma muli o ka maʻi kō, a me ka mumū o ka ʻōpū (enteritis).

Hoʻopili pololei kekahi poʻe i ka cartilage manō i ka ʻili no ka arthritis a me ka psoriasis.

Hoʻopili kekahi poʻe i ka cartilage manō i ka poli no ke kanesa.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no PALAPALA HELU penei:

Kūpono ʻole paha no ...

• Kanesa. ʻO ka hapa nui o nā noiʻi e hōʻike ana i ka lawe ʻana i ka cartilage manō e ka waha ʻaʻole ia e pōmaikaʻi i ka poʻe me nā maʻi maʻi ʻoi loa o ka umauma, kolona, ​​akemāmā, prostate, a me ka lolo. ʻAʻole paha ia e pōmaikaʻi i ka poʻe me ka lymphoma holomua ʻole i mālama mua ʻia. ʻAʻole i aʻo ʻia ka cartilage manō i ka poʻe me ka maʻi ʻaʻai liʻiliʻi i mua.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• ʻO ka tumo maʻi ʻaʻai i kapa ʻia ʻo Kaposi sarcoma. Aia kekahi mau hōʻike e pili ana i ka hoʻopili ʻana o ka mano mano i ka ʻili e hōʻemi paha i nā tumors i kapa ʻia ʻo Kaposi sarcoma. ʻOi pinepine kēia mau tumors i ka poʻe me ka maʻi HIV.
• ʻO Osteoarthritis. Ke hoʻopili ʻia i ka ʻili, nā huahana i loaʻa i ka cartilage manō me ka hoʻohui pū ʻia me nā mea hana ʻē aʻe e hōʻemi ana i nā hōʻailona arthritis. Eia nō naʻe, ʻoi aku ka hoʻomaha ʻia o kekahi hōʻailona ma muli o ka mea camphor a ʻaʻole nā ​​mea ʻē aʻe. Hoʻohui ʻia, ʻaʻohe noiʻi e hōʻike ana i ka lawe ʻia ʻana o ka iwi manō ma loko o ka ʻili.
• ʻO Psoriasis. Ke hōʻike nei ka noiʻi mua i ka poʻe me ka psoriasis plaque kahi hoʻomaʻamaʻa kikoʻī shark cartilage (AE-941) i ka helehelena o nā pā a hoʻoliʻiliʻi i ka makaʻu ke lawe ʻia e ka waha a hoʻopili ʻia i ka ʻili.
• ʻO kekahi ʻano maʻi ʻaʻai kolo i kāhea ʻia i ka carcinoma cell. Lawe i kahi kikoʻī kūʻēhā shark cartilage (AE-941) e ka waha e hoʻonui i ke ola i nā mea maʻi me ka carcinoma pūnana renal.
• Lilo ka hihiʻo e pili ana i ka makahiki.
• Hoola ʻeha.
• Nā kūlana ʻē aʻe.

Pono hou nā hōʻike e hōʻike ai i ka cartilage manō no kēia mau hoʻohana.

Pale ka cartilage manō i ka ulu ʻana o nā kīʻaha koko hou e pono ai no ka ulu ʻana o ka maʻi ʻaʻai. Hiki iā ia ke pale i ka ulu ʻana o nā kīʻaha koko i nā maʻi liona. Kōkua paha kēia i kēia mau ʻeha.

ʻO ka cartilage manō SAFE MAU PONO no ka hapa nui o ka poʻe ke lawe ʻia e ka waha a hiki i 40 mau mahina a i ʻole ke noi ʻia i ka ʻili a hiki i 8 mau pule.

Hiki iā ia ke hoʻonā i kahi ʻono maikaʻi ʻole i ka waha, nausea, luaʻi, ʻōpū o ka ʻōpū, ka paʻa ʻana o ke koko, hoʻoliʻiliʻi, kōpaʻa kiʻekiʻe, nā kiʻekiʻe o ka calcium, nāwaliwali, a me ka luhi. Hiki iā ia ke kumu i ke kīnā ʻole o ke ake. Loaʻa i kekahi mau huahana kahi pilau a ʻono hoʻi.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻAʻole lawa ka ʻike pono e pili ana i ka palekana o ka lawe ʻana i ka cartilage manō inā he hāpai ʻoe a hānai umauma paha. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

"Nā maʻi maʻi autoimmune" e like me sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), a me nā kūlana ʻē aʻe: Hoʻonohonoho ka cartilage shark i ka ʻōnaehana pale e lilo i hana hou. Hiki i kēia ke hoʻonui i nā ʻōuli o nā maʻi autoimmune. Inā loaʻa iā ʻoe kekahi o kēia mau kūlana, ʻoi aku ka maikaʻi o ka hōʻole ʻana i ka hoʻohana ʻana i ka cartilage manō.

Nā pae calcium kiʻekiʻe (hypercalcemia): Hoʻonui ka cartilage shark i nā pae calcium, no laila ʻaʻole pono e hoʻohana ʻia e ka poʻe nona ka pae calcium i kiʻekiʻe loa.

Kānāwai

E akahele me kēia hui ʻana.

Nā lāʻau e hoʻēmi i ka ʻōnaehana pale (Immunosuppressants)

Hoʻonui ka cartilage manō i ka ʻōnaehana pale. Ma ka hoʻonui ʻana i ka ʻōnaehana pale, hoʻoliʻiliʻi ka cartilage manō i ka maikaʻi o nā lāʻau e hōʻemi i ka ʻōnaehana pale.

ʻO kekahi mau lāʻau e hōʻemi ai i ka ʻōnaehana pale pale me azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prac506, ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), a me nā mea ʻē aʻe.

Kalipuna

Hiki i ka cartilage shark ke hāpai i nā pae o ka calcium. Aia kekahi hopohopo i ka hoʻohana ʻana iā ia me nā mea hoʻohui kalima e hoʻoliʻiliʻi loa i nā kiʻekiʻe o ka calcium.

Wai huaʻai

Hiki i ka wai huaʻai ʻākika ke like me ka ʻalani, ʻāpala, hua waina, a i ʻole ka ʻōmato, hiki ke hoʻohaʻahaʻa i ka ikaika o ka cartilage manō ke hala nā minuke. Inā hoʻohui ʻia ka cartilage manō i kahi wai momona, pono e hoʻohui pono ma mua o ka hoʻohana.

ʻO ka mahele kūpono o ka cartilage manō e pili ana i nā kumu like ʻole e like me ka makahiki o ka mea hoʻohana, ke olakino, a me nā ʻano ʻē aʻe. I kēia manawa ʻaʻole lawa ka ʻike ʻepekema e hoʻoholo ai i kahi pae kūpono o nā lāʻau no ka cartilage manō. E hoʻomanaʻo i ka pono ʻole o ka palekana i nā huahana kūlohelohe a hiki i nā dosages ke koʻikoʻi. E mālama pono i nā ʻōkuhi pili i nā lepili huahana a nīnau i kāu kauka lāʻau a i ʻole kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka hoʻohana ʻana.

AE-941, Cartilage de Requin, Cartilage de Requin du Pacifique, Cartilago de Tiburon, Collagène Marin, Extrait de Cartilage de Requin, Liquid de Cartilage Marin, Marine Collagen, Moana Liquid Cartilage, MSI-1256F, Neovastat, Pacific Shark Cartilage, Poudre de Cartilage de Requin, Pākuʻi Kaha Shark Powder, Kaho Shark Cartilage Extract, Sphyrna lewini, Squalus acanthias.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Merly L, Smith SL. ʻO nā pono Pro-inflammatory o ka supplement cartilage shark. Immunopharmacol Immunotoxicol. 2015; 37: 140-7. Nānā kiʻi ʻole.
2. Sakai S, Otake E, Toida T, Goda Y. Ka ʻike o ke kumu o ka chondroitin sulfate i loko o "nā meaʻai olakino". ʻO Chem Pharm Bull (Tokyo). 2007; 55: 299-303. Nānā kiʻi ʻole.
3. PDQ Integrative, Alternative, a me nā papa hoʻoponopono hoʻoponopono Therapies Therapies. Cartilage (Bovine and Shark) (PDQ®): Mana Mana Mana Ola. Nā hōʻuluʻulu manaʻo ʻike PDQ Cancer [Pūnaewele]. Bethesda (MD): National Cancer Institute (US); 2002. 2016 Jul 21. E nānā abstract.
4. Ua hoʻāʻo ʻia ʻo Goldman E. Shark cartilage extract ma ke ʻano he novel psoriasis lapaʻau. Nā Nūhou Nūhou āpau 1998; 29:14.
5. ʻOihana Hoʻokōʻai Meaʻai. Hana ʻo FDA i ka hana kūpaʻa i nā lāʻau lapaʻau i ʻae ʻole ʻia. Ka pepa kamaʻilio a FDA (Kekemapa 10, 1999)
6. Lane W lāua ʻo Milner M. He hoʻohālikelike o ka cartilage manō a me ka cartilage bovine. Townsend Lett 1996; 153: 40-42.
7. Zhuang, L, Wang, B, Shivji, G, a me et al. ʻO AE-941, kahi mea pāpā i ka angiogenesis he hopena anti-inflammatory koʻikoʻi i ka hypersensitivity pili. ʻO J Invest Derm 1997; 108: 633.
8. ʻO Turcotte P. Phase I ka hoʻonui ʻana i ka hopena o AE-941, kahi agena antiangiogenic, i ka mea hoʻomanawanui degeneration macular e pili ana i ka makahiki. ʻO ka ʻaha kūkā ʻo Retina Society (Hawaii, Kekemapa 2, 1999).
9. ʻO Saunder DN. ʻO Angiogenesis antagonist e like me ka mālama ʻana no ka psoriasis: ʻO ka pae I nā hopena hoʻokolohua hoʻokolohua me AE-941. ʻAmelika Hui Pū ʻIa Dermatology ʻAmelika, New Orleans, Louisiana, Malaki 19-24, 1999.
10. ʻO Aeterna Laboratories Inc. Phase III ke aʻo kaulike ʻia o AE-941 (Neovastat; Shark Cartilage Extract) i nā mea maʻi me ka metastatic renal cell carcinoma refactory i ka immunotherapy. 2001.
11. Escudier, B, Patenaude, F, Bukowski, R, a me et al. ʻO ke kumu no ka hoʻokolohua hoʻokolohua pae III me AE-941 (Neovastat (R)) i nā mea maʻi carcinoma cell carenaloma rastactory i ka immunotherapy. Ann Oncol 2000; 11 (kumukanawai 4): 143-144.
12. Dupont E, Alaoui-Jamali M, Wang T, and et al. ʻO ka hana Angiostatic a antitumoral o AE-941 (Neovastat), kahi hakina molekole i loaʻa mai i ka cartilage manō. Nā hana o ka ʻAmelika Hui Pū ʻIa no ka ʻIli ʻIki Pahu 1997; 38: 227.
13. Shimizu-Suganuma, Masum, Mwanatambwe, Milanga, Iida, Kazum, and et al. Ka hopena o ka cartilage manō ma ka ulu ulu ʻana a me ka manawa ola i vivo (hui ākea). E hui ʻo Annu me Am Soc Clin Oncol 1999; 18: A1760.
14. Inoa inoa ʻole ʻO ka hana Angiostatic a me antitumoral o AE-941 (neovastat-R), kahi hakina molekole i loaʻa mai i ka cartilage mano (hālāwai abstract). Kūpono ʻo Pro Annu iā ʻAs Ascc Cancer Res 1997; 38: A1530.
15. Cataldi, JM a me Osborne, DL. Nā hopena o ka cartilage manō ma ka neovascularization tummary tumo ma vivo a me ka hoʻonui ʻana o ka cell i vitro (hui ʻole abstract). Puke Pai FASEB 1995; 9: A135.
16. Jamali MA, Riviere P, Falardeau A, a me et al. Ka hopena o AE-941 (Neovastat), kahi mea hoʻopuka angiogenesis, i ke ʻano metastatic metastatic Lewis lung, ka pono, ka pale ʻana i nā mea ʻona a me ke ola ʻana. ʻO Clin Invest Med 1998; (suppl): S16.
17. ʻO Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, a me Dupont E. Phase I / II hoʻokolokolo ma AE-941 (Neovastat) i nā mea maʻi me ka maʻi ʻaʻai prostate refractory prostate metastatic (hōʻike abstract). ʻO ka hui makahiki o ka hui Urological Association Kanada (Iune 24-27, 2001).
18. Rosenbluth, RJ, Jennis, AA, Cantwell, S, a me et al. ʻO ka cartilage manō waha i ka mālama ʻana i nā mea maʻi me nā tumors lolo mua kiʻekiʻe. ʻO kahi papa pailaka pae II (hālāwai abstract). E hui ʻo Pro Annu me Am Soc Clin Oncol 1999; 18: A554.
19. ʻO Dupont E, Savard RE, Jourdain C, Juneau C, Thibodeau A, Ross N, a me et al. Nā waiwai antiangiogenike o kahi novel cartilage extract: hiki i ka hana o psoriasis. ʻO J Cutan Med Surg 1998; 2: 146-152.
20. Lane IW a me Contreras E. ʻO ke kiʻekiʻe kiʻekiʻe o ka bioactivity (hoʻemi i ka nui o ka tumora nui) i ʻike ʻia i nā mea maʻi maʻi maʻi kūpale i mālama ʻia me nā mea o ka cartilage shark. ʻO J Naturopath Med 1992; 3: 86-88.
21. ʻO Wilson JL. ʻO ka cartilage manō kumuhana e hoʻohaʻahaʻa iā psoriasis. Altern Comp Ther 2000; 6: 291.
22. ʻO Riviere M, Latreille J, a me Falardeau P. AE-941 (Neovastat), kahi mea pāpā i ka angiogenesis: nā hopena hoʻokolohua hoʻokolokolo maʻi maʻi I / II. Hoʻokomo i ka maʻi ʻaukā 1999; 17 (suppl 1): 16-17.
23. Milner M. Kahi alakaʻi no ka hoʻohana ʻana i ka cartilage manō i ka mālama ʻana i ka maʻi kōhō a me nā maʻi hui pū kekahi. ʻO Amer Chiropractor 1999; 21: 40-42.
24. Leitner SP, Rothkopf MM, Haverstick DD, a me et al. ʻElua mau ʻāpana II o ka waha maloʻo maloʻo maloʻo maloʻo (SCP) i nā mea maʻi me ka umauma metastatic a i ʻole ka maʻi ʻaʻai prostate refractory i ka maʻamau maʻamau. ʻO Amer Soc Clin Oncol 1998; 17: A240.
25. Evans WK, Latreille J, Batist G, a me et al. ʻO AE-941, kahi mea pāpā i ka angiogenesis: kumu no ka hoʻomohala ʻana me ka chemotherapy / radiotherapy hoʻokomo i nā mea maʻi me ka maʻi ʻaʻai liʻiliʻi liʻiliʻi ʻole (NSCLC). Nā Pepa i hāʻawi ʻia 1999; S250.
26. Riviere M, Falardeau P, Latreille J, a me et al. ʻO ka hopena o ka hopena maʻi maʻi maʻi maʻi I / II me AE-941 (Neovastat ®) kahi mea pāpā i ka angiogenesis. ʻO Clin Invest Med (kumukanawai) 1998; S14.
27. Riviere M, Alaoui-Jamali M, Falardeau P, a me et al. ʻO Neovastat: kahi mea pāpā i ka angiogenesis me ka hana anti-cancer. Proc Amer Assoc Cancer Res 1998; 39:46.
28. ʻAʻohe mea kākau. ʻO nā neovastat hoʻokolohua hoʻokolohua hoʻokolohua. 2001;
29. Aeterna Laboratories Inc. Phase II hoʻopaʻa haʻawina o AE-941 (Neovastat; Shark Cartilage) i nā mea maʻi me ka hoʻi hou i ka wā mua a i ʻole refactory mau myeloma. 2001. Helu Kāhea ʻIkepili 1-888-349-3232.
30. ʻO Felillionzwalb, I., Pelielo de Mattos, J. C., Bernardo-Filho, M., a me Caldeira-de-Araujo, A. Hoʻomākaukau o ka cartilage Shark: pale i nā lāhui oxygen reactive. Ka Mea Hana Meaola Toxicol 1998; 36: 1079-1084. Nānā kiʻi ʻole.
31. ʻO Coppes, M. J., Anderson, R. A., Egeler, R. M., a me Wolff, J. E. Nā ʻano hana ʻē aʻe no ka mālama ʻana i ka maʻi ʻaʻa kamaliʻi. N Engl.J Med 9-17-1998; 339: 846-847. Nānā kiʻi ʻole.
32. ʻO Davis, P. F., He, Y., Furneaux, R. H., Johnston, P. S., Ruger, B. M., a me Slim, G. C. Ka pāpā ʻana i ka angiogenesis e kaʻai waha ʻana o ka cartilage manō pauka i kahi hoʻohālikelike iole. Microvasc.Res 1997; 54: 178-182. Nānā kiʻi ʻole.
33. ʻO McGuire, T. R., Kazakoff, P. W., Hoie, E. B., a me Fienhold, M. A. Hana antiproliferative o ka cartilage manō me a me ka ʻole o ka tumor necrosis factor-alpha i ka endothelium umbilical vein kanaka. Pharmacotherapy 1996; 16: 237-244. Nānā kiʻi ʻole.
34. Kuettner, K. E. a me Pauli, B. U. Ka pāpā ʻana i ka neovascularization e kahi kumu cartilage. Loaʻa ʻo Ciba.Symp. 1983; 100: 163-173.Nānā kiʻi ʻole.
35. ʻO Lee, A. a me Langer, ʻo R. Shark cartilage kahi mea kaohi o ka angiogenesis tumo. ʻEpekema 9-16-1983; 221: 1185-1187. Nānā kiʻi ʻole.
36. Korman, D. B. [Antiangiogenic a me antitumor nā pono o ka cartilage]. ʻO Vopr.Onkol. 2012; 58: 717-726. Nānā kiʻi ʻole.
37. ʻO Patra, D. a me Sandell, L. J. Antiangiogenic a me nā mole anticancer i ka cartilage. Expert. Rev Mol. Med 2012; 14: e10. Nānā kiʻi ʻole.
38. de Mejia, E. G. a me Dia, V. P. Ke kuleana o nā proteins a me nā peptides i loko o ka apoptosis, angiogenesis, a me nā metastasis o nā hunaola maʻi ʻaʻai. Ka Mate Metastasis Rev 2010; 29: 511-528. Nānā kiʻi ʻole.
39. ʻO Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., a me Safari, E. Ka hopena o ka cartilage shark i loaʻa i ka protein i ka hana NK cells. Immunopharmacol.Immunotoxicol. 2011; 33: 403-409. Nānā kiʻi ʻole.
40. ʻO Lee, S. Y. a me Chung, S. M. Neovastat (AE-941) ke kāohi nei i ke ala o ke ala ea ma o VEGF a me HIF-2 alpha suppression. Vascul.Pharmacol 2007; 47 (5-6): 313-318. Nānā kiʻi ʻole.
41. ʻO Pearson, W., Orth, M. W., Karrow, N. A., Maclusky, N. J., a me Lindinger, M. I. Nā hopena anti-inflammatory a me chondroprotective o nā nutraceuticals mai Sasha's Blend i kahi ʻano hoʻohālikelike cartilage explant o ka hoʻowali. ʻO Mol Nutr Meaʻai Res. 2007; 51: 1020-1030. Nānā kiʻi ʻole.
42. Kim, S., de, A., V, Bouajila, J., Dias, AG, Cyrino, FZ, Bouskela, E., Costa, PR, a me Nepveu, F. Alpha-phenyl-N-tert-butyl nitrone ( PBN) nā mea loaʻa: synthesi a me nā hana pale e kūʻē i nā pohō microvascular i hoʻokomo ʻia e ischemia / reperfusion. ʻO Bioorg. Med Chem 5-15-2007; 15: 3572-3578. Nānā kiʻi ʻole.
43. Merly, L., Simjee, S., a me Smith, S. L. Ke hoʻokomo nei i nā cytokine inflammatory e nā pahu cartilage. Int Immunopharmacol. 2007; 7: 383-391. Nānā kiʻi ʻole.
44. ʻO Moses, M. A., Sudhalter, J., a me Langer, R. ʻIʻike o kahi mea pāpā i ka neovascularization mai ka cartilage. ʻEpekema 6-15-1990; 248: 1408-1410. Nānā kiʻi ʻole.
45. Ratel, D., Glazier, G., Provencal, M., Boivin, D., Beaulieu, E., Gingras, D., a me Beliveau, R. Nā ʻenekia fibrinolytic pololei i hana ʻia i loko o ka shark cartilage extract: hiki ke hana i ka lāʻau therapeutic i vascular nā maʻi ʻO Thromb.Res. 2005; 115 (1-2): 143-152. Nānā kiʻi ʻole.
46. ʻO Gingras, D., Labelle, D., Nyalendo, C., Boivin, D., Demeule, M., Barthomeuf, C., a me Beliveau, ʻo R. ʻO ka antiangiogenic agena Neovastat (AE-941) e hoʻonāukiuki i ka hana plasminogen activator. Hoʻokomo i nā Laau Hou 2004; 22: 17-26. Nānā kiʻi ʻole.
47. Latreille, J., Batist, G., Laberge, F., Champagne, P., Croteau, D., Falardeau, P., Levinton, C., Hariton, C., Evans, WK, a me Dupont, E. Phase ʻO ka hoʻāʻo ʻana o I / II o ka palekana a me ka pono o AE-941 (Neovastat) i ka mālama ʻana i ka maʻi ʻaʻai liʻiliʻi liʻiliʻi ʻole. Ka maʻi maʻi maʻi maʻi maʻi maʻi 2003; 4: 231-236. Nānā kiʻi ʻole.
48. Bukowski, R. M. AE-941, kahi hui antiangiogenic multifunctional: nā hoʻāʻo i ka carcinoma cell pūpū. Expert.Opin.Investig.Drugs 2003; 12: 1403-1411. Nānā kiʻi ʻole.
49. ʻO Jagannath, S., Champagne, P., Hariton, C., a me Dupont, E. Neovastat i ka myeloma maha. Eur.J.Haematol. 2003; 70: 267-268. Nānā kiʻi ʻole.
50. Hāʻawi ʻo FDA i ke kūlana lāʻau lapaʻau makua ʻole iā Aeterna's Neovastat no ka maʻi ʻaʻai kidney. Expert. Rev Anticancer Ther 2002; 2: 618. Nānā kiʻi ʻole.
51. Dupont, E., Falardeau, P., Mousa, SA, Dimitriadou, V., Pepin, MC, Wang, T., a me Alaoui-Jamali, MA Antiangiogenic a me nā antimetastatic waiwai o Neovastat (AE-941), kahi huaʻōlelo e hoʻohana waha. i loaʻa mai i kaʻiʻo cartilage. ʻO Clin Exp Metastasis 2002; 19: 145-153. Nānā kiʻi ʻole.
52. Beliveau, R., Gingras, D., Kruger, EA, Lamy, S., Sirois, P., Simard, B., Sirois, MG, Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, MC, Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, WD, a me Dupont, E. ʻO ka Antiangiogenic Agent Neovastat (AE-941) keakea i ka Votorm Endothelial Growth Factor -ʻO nā hopena biological. ʻO Clin Cancer Res 2002; 8: 1242-1250. Nānā kiʻi ʻole.
53. Weber, M. H., Lee, J., a me Orr, F. W. Ka hopena o Neovastat (AE-941) ma ke ʻano hoʻohālikelike ʻōiwi tumo iwi metastatic. Int J Oncol 2002; 20: 299-303. Nānā kiʻi ʻole.
54. ʻO Barber, R., Delahunt, B., Grebe, S. K., Davis, P. F., Thornton, A., a me Slim, ʻo G. C. ʻAʻole e hoʻopau ka cartilage manamana waha i ka carcinogenesis akā hoʻopaneʻe i ka neʻe ʻana o ka tumo i kahi murine. Anticancer Res 2001; 21 (2A): 1065-1069. Nānā kiʻi ʻole.
55. ʻO Gonzalez, RP, Soares, FS, Farias, RF, Pessoa, C., Leyva, A., Barros Viana, GS, a me Moraes, MO Hōʻike i ka hopena kaohi o ka cartilage manō waha ma ka ulu fibroblast ulu-i hoʻokomo i ka angiogenesis i ka lāpaki. ʻoka. Biol.Pharm.Bull. 2001; 24: 151-154. Nānā kiʻi ʻole.
56. ʻO Brem, H. a me Folkman, J. Kaohi ʻana o ka angiogenesis tumo ma waena o ka cartilage. ʻO J Exp. ʻOihana 2-1-1975; 141: 427-439. Nānā kiʻi ʻole.
57. Koch, A. E. Ke kuleana o angiogenesis i ka rheumatoid arthritis: nā hanana hou. Ann Rheum.Dis. 2000; 59 Pākuʻi 1: i65-i71. Nānā kiʻi ʻole.
58. Kamaʻilio, K. L. a me Harris, A. L. Ke kūlana o kēia manawa no nā antiangiogenic. Br J Haematol. 2000; 109: 477-489. Nānā kiʻi ʻole.
59. ʻO Morris, G. M., Coderre, J. A., Micca, P. L., Lombardo, D. T., a me Hopewell, ʻo J. W. Boron neutron hopu i ka lāʻau o ka iole 9L gliosarcoma: loiloi i nā hopena o ka cartilage manō. Br J Radiol. 2000; 73: 429-434. Nānā kiʻi ʻole.
60. Renckens, C. N. a me van Dam, F. S. [Ka waihona maʻi ʻaʻai lahui (Koningin Wilhelmina Fonds) a me ka Houtsmuller-therapy for cancer]. Ned.Tijdschr.Geneeskd. 7-3-1999; 143: 1431-1433. Nānā kiʻi ʻole.
61. ʻO Moses, MA, Wiederschain, D., Wu, I., Fernandez, CA, Ghazizadeh, V., Lane, WS, Flynn, E., Sytkowski, A., Tao, T., a me Langer, ʻo R. Troponin I i kēia manawa i ka cartilage kanaka a kāpae i ka angiogenesis. Proc Natl .cad.Sci.U.S.A 3-16-1999; 96: 2645-2650. Nānā kiʻi ʻole.
62. Moller HJ, Moller-Pedersen T, Damsgaard TE, Poulsen JH. Hōʻikeʻike o ka suloprate keratin immunogenic i ka chondroitin 6-sulfate ʻoihana mai ka cartilage manō. Nā hopena no ka hoʻāʻo ʻana ELISA. ʻO Clin Chim Acta 1995; 236: 195-204. Nānā kiʻi ʻole.
63. Lu C, Lee JJ, Komaki R, et al. ʻO Chemoradiotherapy me a i ʻole ʻo AE-941 i ke kolamu III non-liʻiliʻi pūkaʻina maʻi ʻaʻai: kahi pae III i hoʻokolokolo ʻia. ʻO J Natl Cancer Inst 2010; 102: 1-7. Nānā kiʻi ʻole.
64. Loprinzi CL, Levitt R, Barton DL, et al. Ka loiloi ʻana i ka cartilage manō i nā mea maʻi me ka maʻi ʻaʻai nui: kahi hoʻokolokolo ʻana o ka North Central Cancer Treatment Group. Kanesa 2005; 104: 176-82. Nānā kiʻi ʻole.
65. Batist G, Patenaude F, Champagne P, et al. ʻO Neovastat (AE-941) i nā mea maʻi maʻi kanalā hōʻino kino: hōʻike o kahi hoʻokolohua pae II me ʻelua mau pae mahele. Ann Oncol 2002; 13: 1259-63 .. Nānā i ka abstract.
66. Sauder DN, Dekoven J, Champagne P, a me al. ʻO Neovastat (AE-941), kahi mea pāpā i ka angiogenesis: ʻO ka hopena I / II hoʻokolohua hoʻokolohua hoʻokolohua hopena i nā mea maʻi me ka plaque psoriasis. ʻO J Am Acad Dermatol 2002; 47: 535-41. Nānā kiʻi ʻole.
67. ʻO Gingras D, Renaud A, Mousseau N, et al. ʻO ka pāpālina protein matrix e AE-941, kahi hui antiangiogenic multifunctional. Anticancer Res 2001; 21: 145-55 .. Nānā i ka abstract.
68. Falardeau P, Champagne P, Poyet P, et al. ʻO Neovastat, kahi lāʻau antiangiogenic multifunctional hanana maoli, i ka hoʻokolohua hoʻokolohua pae III. Semin Oncol 2001; 28: 620-5 .. Nānā i ka abstract.
69. Boivin D, Gendron S, Beaulieu E, et al. Hoʻokomo ka mea antiangiogenic Neovastat (AE-941) i ka apoptosis cell endothelial. Mol Cancer Ther 2002; 1: 795-802 .. Nānā i ka abstract.
70. ʻO Cohen M, Wolfe R, Mai T, Lewis D. He hoʻokolohua kaulike ʻia, pālua makapō, kahi hoʻokolohua hoʻokolohua ʻia o kahi kalima topical e loaʻa ana i ka sulfosamine sulfate, chondroitin sulfate, a me camphor no ka osteoarthritis o ke kuli J Rheumatol 2003; 30: 523-8 .. Nānā i ka abstract.
71. Mei B, Kuntz HD, Kieser M, Kohler S. Ka hoʻokō ʻana o kahi aila peppermint aila / aila caraway paʻa i ka non-ulcer dispepsia. Arzneimittelforschung 1996; 46: 1149-53. Nānā kiʻi ʻole.
72. Anona Hoʻolaha ʻo AEterna i ka hoʻomaka ʻana o ke kākau inoa hoʻomanawanui no ka hoʻokolohua hoʻokolohua III o ka manawa o ka NIH i kākoʻo ʻia o AE-941 / Neovastat i ka mālama ʻana i ka maʻi ʻaʻai māmā. Hoʻolaha ʻo Aeterna 2000 News 2000 Mei 17.
73. Sheu JR, Fu CC, Tsai ML, Chung WJ. Ka hopena o U-995, kahi manō ikaika i loaʻa i ka cartilage i loaʻa i ka mea hōʻoki, mai ka anti-angiogenesis a me nā anti-tumor. Anticancer Res 1998; 18: 4435-41. Nānā kiʻi ʻole.
74. Fontenele JB, Viana GS, Xavier-Filho J, de-Alencar JW. ʻO ka anti-inflammatory a me ka hana analgesic o kahi ʻāpana i hiki ke hoʻoheheʻe ʻia e ka wai mai ka cartilage manō. ʻO Braz J Med Biol Res 1996; 29: 643-6. Nānā kiʻi ʻole.
75. Fontenele JB, Araujo GB, de Alencar JW, Viana GS. ʻO nā hopena analgesic a me nā anti-inflammatory o ka cartilage manō ma muli o kahi mole peptide a pili ka ʻōnaehana nitric oxide (NO). Biol Pharm Bull 1997; 20: 1151-4. Nānā kiʻi ʻole.
76. ʻO Gomes EM, Souto PR, Felillionzwalb I. ʻO ka cartilage shark me ka hoʻomākaukau e pale i nā hunaola mai ka hydrogen peroxide i hoʻokomo ʻia i ka pōʻino a me ka mutagenesis. ʻO Mutat Res 1996; 367: 204-8. Nānā kiʻi ʻole.
77. Hāpai ʻo Mathews J. Media i ka huhū ma luna o ka cartilage manō e like me ka mālama ʻana i ka maʻi ʻaʻai. ʻO J Natl Cancer Inst 1993; 85: 1190-1. Nānā kiʻi ʻole.
78. Bhargava P, Trocky N, Marshall J, et al. ʻO kahi ʻāpana palekana, ahonui a me ke aʻo ʻana i ka pharmacokinetic o ka piʻi ʻana o ka lāʻau, ke piʻi nei ka lōʻihi o ka hoʻokomo ʻana o MSI-1256F (Squalamine Lactate) i nā mea maʻi me ka maʻi ʻaʻai nui. Proc Am Soc Clinical Oncol 1999; 18: A698.
79. Kalidas M, Hammond LA, Patnaik P, et al. ʻO kahi mahele I a me ka pharmacokinetic (PK) e hoʻopaʻa ai i ka mea hōʻoki angiogenesis, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 2000; 19: A698.
80. Patnaik A, Rowinsky E, Hammond L, et al. ʻO kahi mahele I a me ka pharmacokinetic (PK) e hoʻopaʻa ai i ka mea kū hoʻokahi angiogenesis mea kāohi, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 1999; 18: A622.
81. Evans WK, Latreille J, Batist G, et al. AE-941, kahi mea pāpā i ka angiogenesis: kumu no ka hoʻomohala ʻana me ka chemotherapy / radiotherapy hoʻokomo i nā mea maʻi me ka maʻi ʻaʻai liʻiliʻi liʻiliʻi ʻole (NSCLC). Proc Am Soc Clinical Oncol 1999; 18: A1938.
82. Rosenbluth RJ, Jennis AA, Cantwell S, DeVries J. Oral shark cartilage i ka mālama ʻana i nā mea maʻi me nā tumors lolo mua kiʻekiʻe. Ke aʻo pailaka pae II. Proc Am Soc Clinical Oncol 1999; 18: A554.
83. Leitner SP, Rothkopf MM, Haverstick L, et al. ʻElua mau ʻāpana II o ka waha maloʻo maloʻo maloʻo maloʻo (SCP) i nā mea maʻi (pts) me ka umauma metastatic a i ʻole ka maʻi ʻaʻai prostate refractory i ka maʻamau maʻamau. Proc Am Soc Clinical Oncol 1998; 17: A240.
84. ʻO Natl Cancer Institute CancerNet. Pūnaewele Cartilage: www.cancer.gov (Loaʻa ʻia 18 ʻAukake 2000).
85. Berbari P, Thibodeau A, Germain L, et al Nā hopena antiangiogenic o ka lawelawe waha ʻana o ka wai cartilage wai i nā kānaka. ʻO J Surg Res 1999; 87: 108-13. Nānā kiʻi ʻole.
86. Hillman JD, Peng AT, Gilliam AC, Remick SC. Hoʻomaʻamaʻa iā Kaposi Sarcoma me ka lawelawe waha ʻana o ka cartilage manō ma kahi maʻi kanaka Herpes virus 8-seropositive, Kanaka Immunodeficiency Virus-Seronegative kāne kāne kāne kāne kāne. Arch Dermatol 2001; 137: 1149-52. Nānā kiʻi ʻole.
87. ʻO nā neovastat hoʻokolohua hoʻokolohua hoʻokolohua. Hāʻawi ʻia i ka ʻAmelika Hui Pū ʻIa no ka ʻIliʻIa Cancer i ka hui makahiki 92. 27 Malaki 2001.
88. ʻO Wilson JL. ʻO ka cartilage shark topical e hoʻohaʻahaʻa i ka psoriasis: ka loiloi noiʻi a me nā hopena mua o ke olakino. Hoʻohui Hoʻohui Ther 2000; 6: 291.
89. Miller DR, Anderson GT, Stark JJ, et al. ʻO ka hoʻāʻo I / II o ka palekana a me ka pono o ka cartilage manō i ka mālama ʻana i ka maʻi ʻaʻai kūpuna. ʻO J Clin Oncol 1998; 16: 3649-55. Nānā kiʻi ʻole.
90. Lane IW, Comac L. ʻAʻole loaʻa ka maʻi ʻaʻai i ka manō. Garden City, NY: Pūʻulu Hoʻopuka Avery; 1992.
91. ʻO Hunt TJ, ʻo Connelly JF. ʻO ka cartilage manō no ka mālama ʻana i ka maʻi ʻaʻai. ʻO Am J Health Syst Pharm 1995; 52: 1756-60. Nānā kiʻi ʻole.
92. ʻO Ashar B, ʻo Vargo E. ʻO ka hepatitis cartilage i hoʻokomo ʻia i ka huapalapala [leka]. Ann Intern Med 1996; 125: 780-1. Nānā kiʻi ʻole.

Nānā hope - 03/14/2019